Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
25,203,754
-
Share change
-
+28,667
-
Total reported value
-
$124,779,424
-
Put/Call ratio
-
27%
-
Price per share
-
$4.96
-
Number of holders
-
74
-
Value change
-
+$142,561
-
Number of buys
-
2
Institutional Holders of GALENA BIOPHARMA INC - COM (GALE) as of Q4 2013
As of 31 Dec 2013,
GALENA BIOPHARMA INC - COM (GALE) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,203,754 shares.
The largest 10 holders included
State Street Corp, BlackRock Institutional Trust Company, N.A., Consonance Capital Management LP, BlackRock Fund Advisors, VANGUARD GROUP INC, NORTHERN TRUST CORP, TIAA CREF INVESTMENT MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, Bank of New York Mellon Corp, and UBS AG.
This page lists
74
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.